Who won ASCO? Is pharma sandbagging its blockbusters? And what do gladiators have to do with biotech?
We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. First, STAT’s Matthew Herper joins us to break down the busts and breakthroughs at the biggest annual oncology conference. Then we discuss a Washington Post story, about the reportedly ignored promise of a Pfizer drug, that riled up virtually all of biotech. Finally, STAT’s Kate Sheridan dials in from Philadelphia to dish on the annual BIO conference and an adjacent — and infamous — party.